Related Experiment Videos

L-2-hydroxyglutaric aciduria: clinical heterogeneity versus biochemical homogeneity in a sibship

J B de Klerk1, J G Huijmans, H Stroink

  • 1Department of Pediatrics, Sophia Children's Hospital, Erasmus University Rotterdam, The Netherlands.

Neuropediatrics
|February 7, 1998
PubMed

Insights

L-2-hydroxyglutaric aciduria, a rare metabolic disorder, frequently causes neurological disease in affected siblings. Symptom severity can vary within families, independent of biochemical abnormality levels.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • L-2-hydroxyglutaric aciduria is an inherited metabolic disorder.
  • This study investigates a North-African family with multiple affected siblings.

Observation:

  • Three out of four siblings presented with L-2-hydroxyglutaric aciduria and varying degrees of psychomotor retardation.
  • All affected individuals exhibited increased head circumference.
  • Brain MRI revealed white matter abnormalities consistent with demyelination or spongiosis.

Findings:

  • Biochemical analysis showed similar L-2-hydroxyglutaric acid levels across affected siblings.
  • Cerebrospinal fluid analysis indicated elevated lysine and decreased glutamine in the most severely affected child.
  • Neurological symptoms did not strictly correlate with the extent of biochemical abnormalities.

Implications:

  • L-2-hydroxyglutaric aciduria is strongly associated with neurological impairment.
  • Disease manifestation can be variable within families, suggesting other genetic or environmental factors may influence severity.
  • Further research is needed to understand the full spectrum and pathogenic mechanisms of this disorder.

Related Concept Videos